Company: MVIS
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001641172-25-006436
Chunk: 8

Company: MICROVISION, INC.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 8
---
 regularly scheduled Board meeting, the Chair
of each committee reports on any significant matters addressed by that committee during the quarter. Each director serving on our principal
committees is an independent director pursuant to applicable Nasdaq listing standards and SEC rules.

The current charters for each of our principal committees
can be found on the investor relations section of our website at www.ir.microvision.com. The composition of our principal committees
as of March 31, 2025 was as shown in the table below. We anticipate that some changes in committee composition may be made soon after
the 2025 Annual Meeting.

| Audit Committee           |     | Compensation Committee |     | Nominating & Governance Committee |
| Simon Biddiscombe (Chair) 
 Jeffrey Herbst            
 Jada Smith                |     | Jeffrey Herbst (Chair) 
 Simon Biddiscombe      
 Robert Carlile         
 Dr. Mark Spitzer       |     | Dr. Mark Spitzer (Chair)          
 Robert Carlile                    
 Peter Schabert                    
 Jada Smith                        |

| 7 |

The Audit Committee

Our Audit Committee:

| ● | oversees our accounting and financial reporting processes and the audits of our financial statements and internal control over financial reporting; |
| ● | oversees the qualifications, independence, performance, and engagement of our independent registered public accounting firm;                        |
| ● | oversees our disclosure controls and procedures, and internal audit function;                                                                       |
| ● | reviews and pre-approves all audit and permitted non-audit services and fees;                                                                       |
| ● | reviews and approves all related-person transactions;                                                                                               |
| ● | oversees compliance with policies on business ethics and public responsibility; and                                                                 |
| ● | oversees financial-related risks and the enterprise risk management program, including management of risks related to cybersecurity.                |

Changes to the composition of the committee in 2024
included the appointment of Simon Biddiscombe as Chair and the appointment of Jada Smith as a committee member, replacing Brian Turner.
The Audit Committee met five times and took action by written consent four times during 2024.

The “audit committee financial experts”
designated by the Board are Simon Biddiscombe, Robert Carlile, and Jeffrey Herbst, each an independent director. Mr. Biddiscombe has eleven
years of experience as a chief financial officer of four public companies and nine years of experience in various roles at PricewaterhouseCoopers
LLP. Mr. Carlile has thirty-nine years of experience in various roles in public accounting